EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H30O6 |
| Net Charge | 0 |
| Average Mass | 402.487 |
| Monoisotopic Mass | 402.20424 |
| SMILES | [H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@@]21C |
| InChI | InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1 |
| InChIKey | LRJOMUJRLNCICJ-JZYPGELDSA-N |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. hormone Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. anti-inflammatory agent Any compound that has anti-inflammatory effects. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Prednisolone acetate (CHEBI:8380) has role analgesic (CHEBI:35480) |
| Prednisolone acetate (CHEBI:8380) has role anti-anaemic agent (CHEBI:75835) |
| Prednisolone acetate (CHEBI:8380) has role anti-inflammatory agent (CHEBI:67079) |
| Prednisolone acetate (CHEBI:8380) has role immunosuppressive agent (CHEBI:35705) |
| Prednisolone acetate (CHEBI:8380) has role ophthalmology drug (CHEBI:66981) |
| Prednisolone acetate (CHEBI:8380) is a corticosteroid hormone (CHEBI:36699) |
| Synonyms | Source |
|---|---|
| hydroprednisone acetate | DrugCentral |
| meticortelone acetate | DrugCentral |
| meticotelone acetate | DrugCentral |
| NSC-10966 | ChEMBL |
| Prednisolone 21-acetate | KEGG COMPOUND |
| Prednisolone acetate | KEGG COMPOUND |
| Brand Names | Source |
|---|---|
| Econopred | ChEMBL |
| Flo-pred | ChEMBL |
| Meticortelone | ChEMBL |
| Omnipred | ChEMBL |
| Pred forte | ChEMBL |
| Pred fte | ChEMBL |
| Citations |
|---|